Busby W F, Paglialunga S, Newberne P M, Wogan G N
Cancer Res. 1976 Jun;36(6):2013-8.
Transfer RNA methylase (tRNA methylase) activity and capacity were monitored in whole-rat-liver preparations during the induction of hepatocellular carcinomas by an 8-week aflatoxin B1 dosing regimen that produced minimal toxic effects. Significant phases of elevated tRNA methylase capacity occurred at 6 to 9 weeks (20%) and 24 to 29 weeks (40%). No significant change in tRNA methylase activity was noted over the course of the 55-week experiment. Higher aflatoxin B1 doses, producing acute toxic liver damage, resulted in elevated tRNA methylase activity (50%) and capacity (30%) at least as early as 1 week after dosing. Experiments with individual nodular lesions excised from livers of rats continuously fed a diet containing 2 ppm aflatoxin B1 demonstrated similarly elevated tRNA methylase activities and capacities in hyperplastic (preneoplastic)nodules, with and without histological evidence of carcinoma.
在用黄曲霉毒素B1进行为期8周的给药方案诱导大鼠肝细胞癌的过程中,监测了全大鼠肝脏制剂中的转移RNA甲基化酶(tRNA甲基化酶)活性和能力,该方案产生的毒性作用最小。tRNA甲基化酶能力显著升高的阶段出现在第6至9周(升高20%)和第24至29周(升高40%)。在为期55周的实验过程中,未观察到tRNA甲基化酶活性有显著变化。更高剂量的黄曲霉毒素B1会导致急性毒性肝损伤,至少在给药后1周就会使tRNA甲基化酶活性升高(50%)和能力升高(30%)。对持续喂食含2 ppm黄曲霉毒素B1饮食的大鼠肝脏中切除的单个结节性病变进行的实验表明,在有或无癌组织学证据的增生性(癌前)结节中,tRNA甲基化酶活性和能力同样升高。